Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Mohini Ranganathan, MD
JCP
Original Research
Clinical Outcomes of IV Ketamine for Depression
January 8, 2024
Short-term clinical trials found intravenous (IV) ketamine to be effective in reducing depressive symptoms. This study assessed longer-term outcomes of IV ketamine for depression and explored treatment and patient...
Dara Ganoczy
,
Mohini Ranganathan
,
William S. Gilmer
, et al
JCP
ASCP Corner
Medical Marijuana: What Physicians Need to Know
May 7, 2019
As of March 2019, "medical marijuana" has been approved in 33 states; however, these products are not FDA-regulated. This article summarizes the evidence for marijuana in psychiatric indications, as...
Rajiv Radhakrishnan
,
Mohini Ranganathan
,
Deepak Cyril D' Souza
JCP
ASCP Corner
The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches
March 15, 2014
Christoph U. Correll
,
Swapnil Gupta
,
John D. Cahill
, et al
PCC
Letter to the Editor
Treatment of Hyperprolactinemia and Gynecomastia With Adjunctive Aripiprazole in 2 Men Receiving Long-Acting Injectable Antipsychotics
July 18, 2013
Deepak C. D' Souza
,
Mohini Ranganathan
,
Douglas L. Boggs
, et al
